Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05243797
Title A Study of Teclistamab in Combination With Lenalidomide Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation (MajesTEC-4)
Acronym MajesTEC-4
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors European Myeloma Network
Indications
Therapies
Age Groups: adult | senior
Covered Countries TUR | NOR | NLD | ITA | ISR | IRL | GRC | GBR | FRA | DNK | DEU | CZE | CHE | CAN | BRA | BEL | AUT | AUS


No variant requirements are available.